Carolina Arancibia
Research Fellow
My research background is in Microbiology and Immunology. My interests lie in "regional immunology" and after doing my Ph.D. research in the eye I have moved on to the gut. Currently I am characterizing human intestinal dendritic cells under homeostatic and inflammatory conditions and investigating the role of TGF-beta in IBD.
Recent publications
-
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.
Journal article
Kurioka A. et al, (2018), Front Immunol, 9
-
Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
Journal article
Gwela A. et al, (2017), J Crohns Colitis, 11, 1124 - 1134
-
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Journal article
West NR. et al, (2017), Nat Med, 23, 579 - 589
-
Innate Lymphoid Cells in Intestinal Inflammation.
Journal article
Geremia A. and Arancibia-Cárcamo CV., (2017), Front Immunol, 8
-
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease.
Journal article
de Wit J. et al, (2016), J Allergy Clin Immunol, 137, 960 - 963